Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase 3 33Phase NA 28Phase 1 7Phase 1/2 6Phase 2/3 5Phase 4 2

Status

Completed 49Terminated 9Active not recruiting 8Unknown 6Recruiting 6Withdrawn 5

Sponsor Class

OTHER 650INDUSTRY 339NIH 46OTHER_GOV 29UNKNOWN 8NETWORK 6INDIV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 2Myeloid 1Lymphoid 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2Small Cell Lung Carcinoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

venetoclax 1thymoglobulin 1fludarabine 1atezolizumab 1Pemetrexed 1PM 01183 1Idarubicin 1Cytarabine 1Clofarabine 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × NETWORK × Clear all
NCT04253145 2023-11-18

Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

Fundacion Oncosur

Phase 1/2 Unknown
184 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03505944 2021-10-13

VALERIA

Nordic Lymphoma Group

Phase 1/2 Unknown
59 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT04538313 2020-09-04

A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs

CAR-T (Shanghai) Cell Biotechnology Co., Ltd.

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00838240 2012-07-20

AML-14A

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Unknown
114 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00887042 2012-03-26

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

The Korean Society of Pediatric Hematology Oncology

Phase 1/2 Unknown
35 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00516100 2010-01-15

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Aptium Oncology Research Network

Phase 1/2 Unknown
62 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡